Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412277/
https://www.ncbi.nlm.nih.gov/pubmed/37565221
http://dx.doi.org/10.1155/2023/9892315
_version_ 1785086861417381888
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10412277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104122772023-08-10 Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-08-02 /pmc/articles/PMC10412277/ /pubmed/37565221 http://dx.doi.org/10.1155/2023/9892315 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines
title Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines
title_full Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines
title_fullStr Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines
title_full_unstemmed Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines
title_short Retracted: Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines
title_sort retracted: design and in vitro evaluation of novel cationic lipids for sirna delivery in breast cancer cell lines
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412277/
https://www.ncbi.nlm.nih.gov/pubmed/37565221
http://dx.doi.org/10.1155/2023/9892315
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retracteddesignandinvitroevaluationofnovelcationiclipidsforsirnadeliveryinbreastcancercelllines

Ejemplares similares